Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)-Reference-Cited by-同舟云学术

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Published:2023-03 Issue:10381 Volume:401 Page:1011-1019
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Petri Michelle,Bruce Ian N,Dörner Thomas,Tanaka Yoshiya,Morand Eric F,Kalunian Kenneth C,Cardiel Mario H,Silk Maria E,Dickson Christina L,Meszaros Gabriella,Zhang Lu,Jia Bochao,Zhao Youna,McVeigh Conor J,Mosca Marta

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. New insights into the immunopathogenesis of systemic lupus erythematosus;Tsokos;Nat Rev Rheumatol,2016

2. Diagnosis and management of rheumatoid arthritis: a review;Aletaha;JAMA,2018

3. Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014);Jorge;Rheumatology (Oxford),2018

4. ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study;Kandane-Rathnayake;Arthritis Res Ther,2022

5. Lupus—an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000–2015;Yen;Arthritis Rheumatol,2018

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus Erythematosus: Pathogenesis of Cutaneous Manifestations;International Encyclopedia of Public Health;2025

2. The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2024-09-04

3. JAK2 inhibitor protects the septic heart through enhancing mitophagy in cardiomyocytes;Biomedicine & Pharmacotherapy;2024-09

4. JAK Inhibitors - Pros and Cons Learned from Their Use in Rheumatic Diseases;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-08-20

5. Lupus Nephritis from Pathogenesis to New Therapies: An Update;International Journal of Molecular Sciences;2024-08-18